What is Contraction Alkalosis?
Contraction alkalosis is a metabolic alkalosis that develops when vigorous diuretic therapy causes volume depletion, leading to increased serum bicarbonate concentration through both concentration effects and enhanced renal bicarbonate retention. 1, 2
Pathophysiology
Contraction alkalosis occurs through two primary mechanisms:
Volume contraction concentrates existing bicarbonate in the extracellular fluid as water and chloride are lost through diuresis, mechanically increasing bicarbonate concentration 3, 4
Enhanced renal bicarbonate reabsorption occurs due to multiple factors triggered by volume depletion: activation of the renin-angiotensin-aldosterone system, chloride depletion, increased distal sodium delivery, hypokalemia, and increased urine acidification—all of which promote bicarbonate retention 2, 4
Hypochloremia is a critical maintenance factor, as chloride depletion impairs the kidney's ability to excrete excess bicarbonate, perpetuating the alkalosis even after volume is restored 4
Clinical Context in High-Risk Populations
Heart Failure Patients
Hypokalemia and contraction alkalosis are frequent accompaniments of vigorous diuretic drug use in heart failure patients, particularly when loop diuretics are combined with thiazides or metolazone 1
The combination of metabolic alkalosis with the underlying disease state (which itself causes neurohormonal activation) creates a compounding effect that amplifies the tendency toward alkalosis 2
Ventricular arrhythmias occur in the majority of heart failure patients and are aggravated by the hypokalemia that accompanies contraction alkalosis, making potassium replacement essential (target serum potassium 4.5-5.0 mEq/L) 1
Cirrhosis Patients
Patients with cirrhosis and ascites are highly susceptible to rapid reductions in extracellular fluid volume with loop diuretics, making contraction alkalosis particularly common 1
Loop diuretics can lead to potassium and magnesium depletion, which compounds the alkalosis and increases risk of hepatic encephalopathy (also favored by increased renal ammonia production during alkalosis) 1
Diuretic-Induced Cases
Contraction alkalosis is the most common acid-base disorder in hospitalized patients, particularly those receiving aggressive diuretic therapy 5, 4
The disorder is characterized by elevated serum bicarbonate (>26 mEq/L), elevated CO2, low serum chloride (<95 mmol/L), and arterial pH >7.45 6, 5
Severe metabolic alkalosis (pH ≥7.55) is associated with significantly increased mortality in critically ill patients 5, 4
Key Laboratory Findings
- Elevated serum bicarbonate and CO2 (typically CO2 >30-32 mEq/L) 6
- Low serum chloride (<95 mmol/L), which is both a consequence and maintenance factor 6, 4
- Hypokalemia is nearly universal, as potassium depletion both contributes to and results from the alkalosis 1, 2
- Disproportionate BUN elevation relative to creatinine may be present, reflecting volume depletion 1
Clinical Pitfalls
Do not confuse volume depletion with worsening heart failure: If hypotension and azotemia occur without signs of fluid retention (no jugular venous distension, no peripheral edema), this indicates volume depletion from excessive diuresis rather than disease progression 1
Excessive concern about mild azotemia can lead to underutilization of diuretics and persistent volume overload, which itself compromises outcomes 1
The alkalosis will not resolve without chloride repletion, even if volume is restored with non-chloride-containing fluids 4
Management Principles
Reduce or temporarily discontinue the diuretic to allow volume repletion and permit renal bicarbonate excretion 1, 6
Aggressive potassium chloride replacement (20-60 mEq/day) is required to maintain serum potassium in the 4.5-5.0 mEq/L range; dietary supplementation alone is rarely sufficient 1
Chloride repletion is essential for resolution, as hypochloremia maintains the alkalosis by impairing renal bicarbonate excretion 4
Consider acetazolamide to enhance renal bicarbonate excretion in severe cases, though this must be balanced against the risk of further volume depletion 2
Aldosterone antagonists (spironolactone, amiloride, triamterene) can prevent both hypokalemia and contraction alkalosis when used as part of the diuretic regimen 1, 2
Avoid dangerous hyperkalemia when combining ACE inhibitors with potassium-sparing agents or large doses of oral potassium; careful monitoring is mandatory 1